Design Therapeutics Inc (DSGN)
5.56
+0.24
(+4.51%)
USD |
NASDAQ |
Nov 05, 16:00
5.56
0.00 (0.00%)
After-Hours: 16:26
Design Therapeutics Total Assets (Quarterly): 269.58M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 269.58M |
| March 31, 2024 | 278.79M |
| December 31, 2023 | 289.64M |
| September 30, 2023 | 299.87M |
| June 30, 2023 | 311.63M |
| March 31, 2023 | 324.74M |
| December 31, 2022 | 341.14M |
| September 30, 2022 | 354.57M |
| Date | Value |
|---|---|
| June 30, 2022 | 367.93M |
| March 31, 2022 | 378.80M |
| December 31, 2021 | 390.56M |
| September 30, 2021 | 400.35M |
| June 30, 2021 | 405.15M |
| March 31, 2021 | 411.85M |
| December 31, 2020 | 36.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
36.52M
Minimum
Dec 2020
411.85M
Maximum
Mar 2021
324.08M
Average
341.14M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.34M |
| Shareholders Equity (Quarterly) | 261.24M |